Top Most 8+ When To Stop Diuretics In Heart Failure
-
1.Diuretics And Heart Failure Technique: Outpatient, Inpatient, Potassium-sparing Diuretics
Congestive heart failure (CHF) is one of the most common chronic conditions in the United States, affecting an estimated 5.7 million people and is the leading diagnosis for hospitalized patients.
View more » -
2.Acute/Worsening Heart Failure: Treatment For Fluid Overload
Hospitalisation for acute heart failure (AHF) is associated with high mortality and high rehospitalisation rates. In the absence of evidence-based therapy, treatment is aimed at stabilisation
View more » -
3.Can People In Heart Failure Safely Reduce Diuretics?
Diuretics help people with heart failure reduce excess fluids that can cause shortness of breath, swollen legs, coughing and weight gain.
View more » -
4.Heart Failure - Fluids And Diuretics Information | Mount Sinai - New York
Learn about Heart failure - fluids and diuretics or find a doctor at Mount Sinai Health System.
View more » -
5.Diuretic Withdrawal Is Safe For Stable Heart Failure Patients
Your access to the latest cardiovascular news, science, tools and resources.
View more » -
6.Common Mistakes In Treating Heart Failure
Read “Common mistakes in treating heart failure ” and other informative articles in Today’s Hospitalist. Follow us for news & tips in the medical career field.
View more » -
7.Diuretic Therapy For Heart Failure Patients - American College Of Cardiology
Ragavendra R. Baliga, MBBS, FACC
View more » -
8.Reducing Readmissions For Congestive Heart Failure
Hospital admission for congestive heart failure is extremely common and quite expensive, although it is frequently preventable. New drugs and therapies have been reported to reduce admissions, decrease morbidity and mortality, and improve the quality of life for these patients. Patients with an ejection fraction less than 40 percent (decreased systolic function) should be treated with medication to improve symptoms and prevent progression of heart failure. Angiotensin-converting enzyme (ACE) inhibitors are a mainstay of treatment in patients who can tolerate them; in patients who cannot take these drugs, angiotensin II receptor blocking agents offer an alternative. Patients with New York Heart Association class II or III heart failure should also receive a beta blocker (metoprolol, carvedilol or bisoprolol). Recent research has shown that treatment with spironolactone improves mortality and hospital readmission rates. An exercise program should also be recommended for all patients with heart failure unless their condition is unstable.
View more »